|
Issue |
Title |
|
Vol 5, Issue 2 (2025) |
Personalized Medicine in Neurology |
Abstract
PDF (Eng)
|
Diana V. Dmitrenko |
|
Vol 3, Issue 1 (2023) |
Personalized Methodological Approaches to the Issues of Monitoring the Effectiveness and Safety of Pharmacotherapy with Antiepileptic Drugs Based on Mobile Medicine Technologies |
Abstract
PDF (Eng)
|
V. V. Arkhipov, K. M. Mantserov |
|
Vol 4, Issue 3 (2024) |
Personalized Psychiatry and Neurology: Step by Step |
Abstract
PDF (Eng)
|
L. Yu. Panteleeva |
|
Vol 1, Issue 2 (2021) |
Personalized psychiatry: achievements and prospects |
Abstract
PDF (Eng)
|
O. V. Limankin |
|
Vol 1, Issue 2 (2021) |
Perspectives of personalized approach to prevention and treatment of anticonvulsant-induced osteoporosis via action on vitamin D exchange and VDR expression |
Abstract
PDF (Eng)
|
E. A. Dontseva, V. V. Trefilova, T. E. Popova, M. M. Petrova, M. Al-Zamil |
|
Vol 3, Issue 2 (2023) |
Pharmacogenetic Factors of Clozapine-Induced Metabolic Syndrome |
Abstract
PDF (Eng)
|
A. K. Khasanova |
|
Vol 2, Issue 1 (2022) |
Pharmacogenetic Testing of Antipsychotic Transporter Proteins: A Case Report in a 32-Year-Old Woman with Treatment-Resistant Schizophrenia |
Abstract
PDF (Eng)
|
S M. Osipova, N. A. Shnayder |
|
Vol 2, Issue 1 (2022) |
Pharmacogenetic Testing of Cytochrome P450 Metabolizing Enzymes in 28-Year-Old Man with Treatment-Resistant Schizophrenia |
Abstract
PDF (Eng)
|
A. K. Abdyrakhmanova, R. F. Nasyrova |
|
Vol 2, Issue 2 (2022) |
Pharmacogenetic Testing of Cytochrome P450 System Enzymes in the Therapy of Bipolar Affective Disorder |
Abstract
PDF (Eng)
|
A. K. Khasanova, R. F. Nasyrova |
|
Vol 1, Issue 1 (2021) |
Pharmacogenetics of chlorpromazine and its role in the development of antipsychotic-induced parkinsonism |
Abstract
PDF (Eng)
|
E. E. Vaiman, M. A. Novitsky, R. F. Nasyrova |
|
61 - 70 of 99 Items |
<< < 2 3 4 5 6 7 8 9 10 > >> |